Khalis Mustafayev, Oncology Transplant ID Fellow at MD Anderson Cancer Center, shared a post on LinkedIn about an article he and his colleagues co-authored.
“Our New Article!
In a U.S. national cohort of 11,074 patients with SCLC brain metastases, treatment modality and access to care were key drivers of survival.
Disparities in socioeconomic status, age, sex, insurance coverage, and care setting continued to affect survival.”
Title: Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis
Authors: Khalid Ahmad Qidwai, Zouina Sarfraz, Khalis Mustafayev, Lydia C Hodgson, Arun Maharaj, Triparna Sen, Tulika Ranjan, Manmeet S Ahluwalia
More posts about SCLC on OncoDaily.